Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NT5E | P21589 | 1/20 | 0.34 |
| ▸ | RPS6KA3 | P51812 | 2/20 | 0.31 |
| ▸ | HPGD | P15428 | 1/20 | 0.30 |
| ▸ | TSHR | P16473 | 1/20 | 0.30 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.30 |
| ▸ | ADORA2A | P29274 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6948090 | 0.84 | ADORA2A (0.41) | NT5EHPGDHSD17B10ADORA2A | |
| SCHEMBL6942099 | 0.76 | MKNK2 (0.40) | TSHRHSD17B10ADORA2A | |
| SCHEMBL29602591 | 0.68 | HTT (0.55) | HPGDTSHRHSD17B10 | |
| SCHEMBL14983420 | 0.63 | PI4KA (0.39) | ADORA2A | |
| SCHEMBL14983418 | 0.63 | PI4KA (0.40) | HPGDADORA2A | |
| SCHEMBL31289390 | 0.61 | HPRT1 (0.42) | — | |
| SCHEMBL9664125 | 0.60 | NPC1 (0.44) | HPGDHSD17B10 | |
| SCHEMBL14983415 | 0.60 | PI4KA (0.35) | HPGDTSHRHSD17B10ADORA2A | |
| SCHEMBL29139810 | 0.59 | FGFR1 (0.47) | ADORA2A | |
| SCHEMBL7078189 | 0.59 | ALOX5 (0.46) | HPGDTSHRHSD17B10ADORA2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1349857-A1 | PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS | VERNALIS RESEARCH LIMITED (GB) | 2003-10-08 | — | — | EP | disclosed |
| WO-2002055521-A1 | PURINE DERIVATIVES AS PURINERGIC RECEPTOR ANTAGONISTS | VERNALIS RESEARCH LIMITED (GB) | 2002-07-18 | — | — | WO | disclosed |